Cyclin-Dependent Kinase 6 Phosphorylates NF-κB P65 at Serine 536 and Contributes to the Regulation of Inflammatory Gene Expression | PLOS ONE
Therapy after cyclin‐dependent kinase inhibition in metastatic hormone receptor‐positive breast cancer: Resistance mechanisms and novel treatment strategies - Sharifi - 2020 - Cancer - Wiley Online Library
NF‐κB signaling in inflammation and cancer - Zhang - 2021 - MedComm - Wiley Online Library
Model of HIF regulation over NF-κB pathway. | Download Scientific Diagram
A purified and reconstituted CDK6/cyclin complex phosphorylates NF-kB... | Download Scientific Diagram
Cyclin-Dependent Kinase 6 Phosphorylates NF-kB P65 at Serine 536 and Contributes to the Regulation of Inflammatory Gene Expressi
CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells | Molecular Cancer | Full Text
CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells | Molecular Cancer | Full Text
Role of IκB kinase in tumorigenesis | Future Oncology
Schematic presentation of the mechanism by which Cdk6 inhibits... | Download Scientific Diagram
Targeting the PI3K/AKT/mTOR/NF?B Axis in Ovarian Cancer
Intrinsic and acquired resistance to CDK4/6 inhibitors and potential overcoming strategies | Acta Pharmacologica Sinica
CDK6—a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation | Oncogene
NF-κB inhibitors in treatment and prevention of lung cancer - ScienceDirect
Mechanisms of Sensitivity and Resistance to CDK4/6 Inhibition
Phosphorylation of NF-κB in Cancer | IntechOpen
Cancers | Free Full-Text | Targeting NF-κB Signaling for Multiple Myeloma
Biomolecules | Free Full-Text | Phosphorylation of the Regulators, a Complex Facet of NF-κB Signaling in Cancer
Cyclin-Dependent Kinase 6 Phosphorylates NF-κB P65 at Serine 536 and Contributes to the Regulation of Inflammatory Gene Expression | PLOS ONE
Feed-forward regulatory loop driven by IRF4 and NF-κB in adult T-cell leukemia/lymphoma - ScienceDirect
Inhibiting CDK6 Activity by Quercetin Is an Attractive Strategy for Cancer Therapy | ACS Omega
Inducible deletion of CDK4 and CDK6 – deciphering CDK4/6 inhibitor effects in the hematopoietic system | Haematologica
Pharmaceuticals | Free Full-Text | CDK4/6 and MAPK—Crosstalk as Opportunity for Cancer Treatment
